The global market for Pet Whole Blood and Blood Components was valued at US$ 751 million in the year 2024 and is projected to reach a revised size of US$ 1445 million by 2031, growing at a CAGR of 9.8% during the forecast period.

Pet Whole Blood and Blood Components Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Pet Whole Blood and Blood Components competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

In 2024, the global production of Pet Whole Blood and Blood Components reached 913.51 kiloliters, with an average selling price of US$822 per liter. Pet blood products refer to blood components and plasma proteins derived from healthy animal blood, produced through separation, purification, or recombinant DNA technology, for use in treating pet diseases. Key types include fresh whole blood, frozen or refrigerated whole blood, plasma (fresh frozen plasma, stored frozen plasma), red blood cell concentrates, and plasma proteins (such as canine albumin injection). These products are used to treat hypovolemia, coagulation disorders, and hypoproteinemia caused by anemia, trauma, poisoning, or disease. With the growing number of pet chronic diseases, surgical procedures, and emergency medical situations, a stable, safe, and standardized blood supply system is becoming increasingly urgent.

North American market for Pet Whole Blood and Blood Components is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Pet Whole Blood and Blood Components is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Pet Whole Blood and Blood Components include Thermo Fisher Scientific, Moregate BioTech, Bovogen Biologicals (ANZCO Foods Healthcare), Pel-Freez, LLC, HemoStat Laboratories, CellSera Australia (Auckland BioSciences), Animal Technologies, Serana Europe, Lake Immunogenics, MoreCare. Inc., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Pet Whole Blood and Blood Components, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pet Whole Blood and Blood Components.

The Pet Whole Blood and Blood Components market size, estimations, and forecasts are provided in terms of sales volume (KL) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pet Whole Blood and Blood Components market comprehensively. Regional market sizes, concerning products by Type, by Application, by Components and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Pet Whole Blood and Blood Components manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, by Components and by regions.

Scope of Pet Whole Blood and Blood Components Market Report

Report Metric	Details
Report Name	Pet Whole Blood and Blood Components Market
Accounted market size in year	US$ 751 million
Forecasted market size in 2031	US$ 1445 million
CAGR	9.8%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Canine Feline Bovine Sheep Others
Segment by Components	Pet Whole Blood Blood Components
Segment by Application	Veterinary Hospital Clinic Other
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Thermo Fisher Scientific, Moregate BioTech, Bovogen Biologicals (ANZCO Foods Healthcare), Pel-Freez, LLC, HemoStat Laboratories, CellSera Australia (Auckland BioSciences), Animal Technologies, Serana Europe, Lake Immunogenics, MoreCare. Inc., Nanjing BioChannel Biotechnology Co., Ltd
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pet Whole Blood and Blood Components manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pet Whole Blood and Blood Components in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Pet Whole Blood and Blood Components Market growing?

Ans: The Pet Whole Blood and Blood Components Market witnessing a CAGR of 9.8% during the forecast period 2025-2031.

What is the Pet Whole Blood and Blood Components Market size in 2031?

Ans: The Pet Whole Blood and Blood Components Market size in 2031 will be US$ 1445 million.

Who are the main players in the Pet Whole Blood and Blood Components Market report?

Ans: The main players in the Pet Whole Blood and Blood Components Market are Thermo Fisher Scientific, Moregate BioTech, Bovogen Biologicals (ANZCO Foods Healthcare), Pel-Freez, LLC, HemoStat Laboratories, CellSera Australia (Auckland BioSciences), Animal Technologies, Serana Europe, Lake Immunogenics, MoreCare. Inc., Nanjing BioChannel Biotechnology Co., Ltd

What are the Application segmentation covered in the Pet Whole Blood and Blood Components Market report?

Ans: The Applications covered in the Pet Whole Blood and Blood Components Market report are Veterinary Hospital, Clinic, Other

What are the Type segmentation covered in the Pet Whole Blood and Blood Components Market report?

Ans: The Types covered in the Pet Whole Blood and Blood Components Market report are Canine, Feline, Bovine, Sheep, Others

1 Pet Whole Blood and Blood Components Market Overview

1.1 Product Definition

1.2 Pet Whole Blood and Blood Components by Type

1.2.1 Global Pet Whole Blood and Blood Components Market Value Comparison by Type (2024 VS 2031)

1.2.2 Canine

1.2.3 Feline

1.2.4 Bovine

1.2.5 Sheep

1.2.6 Others

1.3 Pet Whole Blood and Blood Components by Components

1.3.1 Global Pet Whole Blood and Blood Components Market Value Comparison by Components: 2024 VS 2031

1.3.2 Pet Whole Blood

1.3.3 Blood Components

1.4 Pet Whole Blood and Blood Components by Application

1.4.1 Global Pet Whole Blood and Blood Components Market Value by Application (2024 VS 2031)

1.4.2 Veterinary Hospital

1.4.3 Clinic

1.4.4 Other

1.5 Global Pet Whole Blood and Blood Components Market Size Estimates and Forecasts

1.5.1 Global Pet Whole Blood and Blood Components Revenue 2020-2031

1.5.2 Global Pet Whole Blood and Blood Components Sales 2020-2031

1.5.3 Global Pet Whole Blood and Blood Components Market Average Price (2020-2031)

1.6 Assumptions and Limitations

2 Pet Whole Blood and Blood Components Market Competition by Manufacturers

2.1 Global Pet Whole Blood and Blood Components Sales Market Share by Manufacturers (2020-2025)

2.2 Global Pet Whole Blood and Blood Components Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Pet Whole Blood and Blood Components Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Pet Whole Blood and Blood Components, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Pet Whole Blood and Blood Components, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Pet Whole Blood and Blood Components, Product Type & Application

2.7 Global Key Manufacturers of Pet Whole Blood and Blood Components, Date of Enter into This Industry

2.8 Global Pet Whole Blood and Blood Components Market Competitive Situation and Trends

2.8.1 Global Pet Whole Blood and Blood Components Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Pet Whole Blood and Blood Components Players Market Share by Revenue

2.8.3 Global Pet Whole Blood and Blood Components Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Pet Whole Blood and Blood Components Market Scenario by Region

3.1 Global Pet Whole Blood and Blood Components Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Pet Whole Blood and Blood Components Sales by Region: 2020-2031

3.2.1 Global Pet Whole Blood and Blood Components Sales by Region: 2020-2025

3.2.2 Global Pet Whole Blood and Blood Components Sales by Region: 2026-2031

3.3 Global Pet Whole Blood and Blood Components Revenue by Region: 2020-2031

3.3.1 Global Pet Whole Blood and Blood Components Revenue by Region: 2020-2025

3.3.2 Global Pet Whole Blood and Blood Components Revenue by Region: 2026-2031

3.4 North America Pet Whole Blood and Blood Components Market Facts & Figures by Country

3.4.1 North America Pet Whole Blood and Blood Components Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Pet Whole Blood and Blood Components Sales by Country (2020-2031)

3.4.3 North America Pet Whole Blood and Blood Components Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Pet Whole Blood and Blood Components Market Facts & Figures by Country

3.5.1 Europe Pet Whole Blood and Blood Components Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Pet Whole Blood and Blood Components Sales by Country (2020-2031)

3.5.3 Europe Pet Whole Blood and Blood Components Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Pet Whole Blood and Blood Components Market Facts & Figures by Region

3.6.1 Asia Pacific Pet Whole Blood and Blood Components Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Pet Whole Blood and Blood Components Sales by Region (2020-2031)

3.6.3 Asia Pacific Pet Whole Blood and Blood Components Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Pet Whole Blood and Blood Components Market Facts & Figures by Country

3.7.1 Latin America Pet Whole Blood and Blood Components Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Pet Whole Blood and Blood Components Sales by Country (2020-2031)

3.7.3 Latin America Pet Whole Blood and Blood Components Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Pet Whole Blood and Blood Components Market Facts & Figures by Country

3.8.1 Middle East and Africa Pet Whole Blood and Blood Components Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Pet Whole Blood and Blood Components Sales by Country (2020-2031)

3.8.3 Middle East and Africa Pet Whole Blood and Blood Components Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Pet Whole Blood and Blood Components Sales by Type (2020-2031)

4.1.1 Global Pet Whole Blood and Blood Components Sales by Type (2020-2025)

4.1.2 Global Pet Whole Blood and Blood Components Sales by Type (2026-2031)

4.1.3 Global Pet Whole Blood and Blood Components Sales Market Share by Type (2020-2031)

4.2 Global Pet Whole Blood and Blood Components Revenue by Type (2020-2031)

4.2.1 Global Pet Whole Blood and Blood Components Revenue by Type (2020-2025)

4.2.2 Global Pet Whole Blood and Blood Components Revenue by Type (2026-2031)

4.2.3 Global Pet Whole Blood and Blood Components Revenue Market Share by Type (2020-2031)

4.3 Global Pet Whole Blood and Blood Components Price by Type (2020-2031)

5 Segment by Application

5.1 Global Pet Whole Blood and Blood Components Sales by Application (2020-2031)

5.1.1 Global Pet Whole Blood and Blood Components Sales by Application (2020-2025)

5.1.2 Global Pet Whole Blood and Blood Components Sales by Application (2026-2031)

5.1.3 Global Pet Whole Blood and Blood Components Sales Market Share by Application (2020-2031)

5.2 Global Pet Whole Blood and Blood Components Revenue by Application (2020-2031)

5.2.1 Global Pet Whole Blood and Blood Components Revenue by Application (2020-2025)

5.2.2 Global Pet Whole Blood and Blood Components Revenue by Application (2026-2031)

5.2.3 Global Pet Whole Blood and Blood Components Revenue Market Share by Application (2020-2031)

5.3 Global Pet Whole Blood and Blood Components Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Thermo Fisher Scientific

6.1.1 Thermo Fisher Scientific Company Information

6.1.2 Thermo Fisher Scientific Description and Business Overview

6.1.3 Thermo Fisher Scientific Pet Whole Blood and Blood Components Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Thermo Fisher Scientific Pet Whole Blood and Blood Components Product Portfolio

6.1.5 Thermo Fisher Scientific Recent Developments/Updates

6.2 Moregate BioTech

6.2.1 Moregate BioTech Company Information

6.2.2 Moregate BioTech Description and Business Overview

6.2.3 Moregate BioTech Pet Whole Blood and Blood Components Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Moregate BioTech Pet Whole Blood and Blood Components Product Portfolio

6.2.5 Moregate BioTech Recent Developments/Updates

6.3 Bovogen Biologicals (ANZCO Foods Healthcare)

6.3.1 Bovogen Biologicals (ANZCO Foods Healthcare) Company Information

6.3.2 Bovogen Biologicals (ANZCO Foods Healthcare) Description and Business Overview

6.3.3 Bovogen Biologicals (ANZCO Foods Healthcare) Pet Whole Blood and Blood Components Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Bovogen Biologicals (ANZCO Foods Healthcare) Pet Whole Blood and Blood Components Product Portfolio

6.3.5 Bovogen Biologicals (ANZCO Foods Healthcare) Recent Developments/Updates

6.4 Pel-Freez, LLC

6.4.1 Pel-Freez, LLC Company Information

6.4.2 Pel-Freez, LLC Description and Business Overview

6.4.3 Pel-Freez, LLC Pet Whole Blood and Blood Components Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Pel-Freez, LLC Pet Whole Blood and Blood Components Product Portfolio

6.4.5 Pel-Freez, LLC Recent Developments/Updates

6.5 HemoStat Laboratories

6.5.1 HemoStat Laboratories Company Information

6.5.2 HemoStat Laboratories Description and Business Overview

6.5.3 HemoStat Laboratories Pet Whole Blood and Blood Components Sales, Revenue and Gross Margin (2020-2025)

6.5.4 HemoStat Laboratories Pet Whole Blood and Blood Components Product Portfolio

6.5.5 HemoStat Laboratories Recent Developments/Updates

6.6 CellSera Australia (Auckland BioSciences)

6.6.1 CellSera Australia (Auckland BioSciences) Company Information

6.6.2 CellSera Australia (Auckland BioSciences) Description and Business Overview

6.6.3 CellSera Australia (Auckland BioSciences) Pet Whole Blood and Blood Components Sales, Revenue and Gross Margin (2020-2025)

6.6.4 CellSera Australia (Auckland BioSciences) Pet Whole Blood and Blood Components Product Portfolio

6.6.5 CellSera Australia (Auckland BioSciences) Recent Developments/Updates

6.7 Animal Technologies

6.7.1 Animal Technologies Company Information

6.7.2 Animal Technologies Description and Business Overview

6.7.3 Animal Technologies Pet Whole Blood and Blood Components Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Animal Technologies Pet Whole Blood and Blood Components Product Portfolio

6.7.5 Animal Technologies Recent Developments/Updates

6.8 Serana Europe

6.8.1 Serana Europe Company Information

6.8.2 Serana Europe Description and Business Overview

6.8.3 Serana Europe Pet Whole Blood and Blood Components Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Serana Europe Pet Whole Blood and Blood Components Product Portfolio

6.8.5 Serana Europe Recent Developments/Updates

6.9 Lake Immunogenics

6.9.1 Lake Immunogenics Company Information

6.9.2 Lake Immunogenics Description and Business Overview

6.9.3 Lake Immunogenics Pet Whole Blood and Blood Components Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Lake Immunogenics Pet Whole Blood and Blood Components Product Portfolio

6.9.5 Lake Immunogenics Recent Developments/Updates

6.10 MoreCare. Inc.

6.10.1 MoreCare. Inc. Company Information

6.10.2 MoreCare. Inc. Description and Business Overview

6.10.3 MoreCare. Inc. Pet Whole Blood and Blood Components Sales, Revenue and Gross Margin (2020-2025)

6.10.4 MoreCare. Inc. Pet Whole Blood and Blood Components Product Portfolio

6.10.5 MoreCare. Inc. Recent Developments/Updates

6.11 Nanjing BioChannel Biotechnology Co., Ltd

6.11.1 Nanjing BioChannel Biotechnology Co., Ltd Company Information

6.11.2 Nanjing BioChannel Biotechnology Co., Ltd Description and Business Overview

6.11.3 Nanjing BioChannel Biotechnology Co., Ltd Pet Whole Blood and Blood Components Sales, Revenue and Gross Margin (2020-2025)

6.11.4 Nanjing BioChannel Biotechnology Co., Ltd Pet Whole Blood and Blood Components Product Portfolio

6.11.5 Nanjing BioChannel Biotechnology Co., Ltd Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Pet Whole Blood and Blood Components Industry Chain Analysis

7.2 Pet Whole Blood and Blood Components Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Pet Whole Blood and Blood Components Production Mode & Process Analysis

7.4 Pet Whole Blood and Blood Components Sales and Marketing

7.4.1 Pet Whole Blood and Blood Components Sales Channels

7.4.2 Pet Whole Blood and Blood Components Distributors

7.5 Pet Whole Blood and Blood Components Customer Analysis

8 Pet Whole Blood and Blood Components Market Dynamics

8.1 Pet Whole Blood and Blood Components Industry Trends

8.2 Pet Whole Blood and Blood Components Market Drivers

8.3 Pet Whole Blood and Blood Components Market Challenges

8.4 Pet Whole Blood and Blood Components Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Thermo Fisher Scientific

Moregate BioTech

Bovogen Biologicals (ANZCO Foods Healthcare)

Pel-Freez, LLC

HemoStat Laboratories

CellSera Australia (Auckland BioSciences)

Nanjing BioChannel Biotechnology Co., Ltd

List of Tables

Table 1. Global Pet Whole Blood and Blood Components Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Pet Whole Blood and Blood Components Market Value by Components, (US$ Million) & (2024 VS 2031)

Table 3. Global Pet Whole Blood and Blood Components Market Value by Application (2024 VS 2031) & (US$ Million)

Table 4. Global Pet Whole Blood and Blood Components Market Competitive Situation by Manufacturers in 2024

Table 5. Global Pet Whole Blood and Blood Components Sales (KL) of Key Manufacturers (2020-2025)

Table 6. Global Pet Whole Blood and Blood Components Sales Market Share by Manufacturers (2020-2025)

Table 7. Global Pet Whole Blood and Blood Components Revenue (US$ Million) by Manufacturers (2020-2025)

Table 8. Global Pet Whole Blood and Blood Components Revenue Share by Manufacturers (2020-2025)

Table 9. Global Market Pet Whole Blood and Blood Components Average Price (US$/L) of Key Manufacturers (2020-2025)

Table 10. Global Key Players of Pet Whole Blood and Blood Components, Industry Ranking, 2022 VS 2023 VS 2024

Table 11. Global Key Manufacturers of Pet Whole Blood and Blood Components, Manufacturing Sites & Headquarters

Table 12. Global Key Manufacturers of Pet Whole Blood and Blood Components, Product Type & Application

Table 13. Global Key Manufacturers of Pet Whole Blood and Blood Components, Date of Enter into This Industry

Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 15. Global Pet Whole Blood and Blood Components by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pet Whole Blood and Blood Components as of 2024)

Table 16. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 17. Global Pet Whole Blood and Blood Components Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 18. Global Pet Whole Blood and Blood Components Sales by Region (2020-2025) & (KL)

Table 19. Global Pet Whole Blood and Blood Components Sales Market Share by Region (2020-2025)

Table 20. Global Pet Whole Blood and Blood Components Sales by Region (2026-2031) & (KL)

Table 21. Global Pet Whole Blood and Blood Components Sales Market Share by Region (2026-2031)

Table 22. Global Pet Whole Blood and Blood Components Revenue by Region (2020-2025) & (US$ Million)

Table 23. Global Pet Whole Blood and Blood Components Revenue Market Share by Region (2020-2025)

Table 24. Global Pet Whole Blood and Blood Components Revenue by Region (2026-2031) & (US$ Million)

Table 25. Global Pet Whole Blood and Blood Components Revenue Market Share by Region (2026-2031)

Table 26. North America Pet Whole Blood and Blood Components Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 27. North America Pet Whole Blood and Blood Components Sales by Country (2020-2025) & (KL)

Table 28. North America Pet Whole Blood and Blood Components Sales by Country (2026-2031) & (KL)

Table 29. North America Pet Whole Blood and Blood Components Revenue by Country (2020-2025) & (US$ Million)

Table 30. North America Pet Whole Blood and Blood Components Revenue by Country (2026-2031) & (US$ Million)

Table 31. Europe Pet Whole Blood and Blood Components Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 32. Europe Pet Whole Blood and Blood Components Sales by Country (2020-2025) & (KL)

Table 33. Europe Pet Whole Blood and Blood Components Sales by Country (2026-2031) & (KL)

Table 34. Europe Pet Whole Blood and Blood Components Revenue by Country (2020-2025) & (US$ Million)

Table 35. Europe Pet Whole Blood and Blood Components Revenue by Country (2026-2031) & (US$ Million)

Table 36. Asia Pacific Pet Whole Blood and Blood Components Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 37. Asia Pacific Pet Whole Blood and Blood Components Sales by Region (2020-2025) & (KL)

Table 38. Asia Pacific Pet Whole Blood and Blood Components Sales by Region (2026-2031) & (KL)

Table 39. Asia Pacific Pet Whole Blood and Blood Components Revenue by Region (2020-2025) & (US$ Million)

Table 40. Asia Pacific Pet Whole Blood and Blood Components Revenue by Region (2026-2031) & (US$ Million)

Table 41. Latin America Pet Whole Blood and Blood Components Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 42. Latin America Pet Whole Blood and Blood Components Sales by Country (2020-2025) & (KL)

Table 43. Latin America Pet Whole Blood and Blood Components Sales by Country (2026-2031) & (KL)

Table 44. Latin America Pet Whole Blood and Blood Components Revenue by Country (2020-2025) & (US$ Million)

Table 45. Latin America Pet Whole Blood and Blood Components Revenue by Country (2026-2031) & (US$ Million)

Table 46. Middle East and Africa Pet Whole Blood and Blood Components Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 47. Middle East and Africa Pet Whole Blood and Blood Components Sales by Country (2020-2025) & (KL)

Table 48. Middle East and Africa Pet Whole Blood and Blood Components Sales by Country (2026-2031) & (KL)

Table 49. Middle East and Africa Pet Whole Blood and Blood Components Revenue by Country (2020-2025) & (US$ Million)

Table 50. Middle East and Africa Pet Whole Blood and Blood Components Revenue by Country (2026-2031) & (US$ Million)

Table 51. Global Pet Whole Blood and Blood Components Sales (KL) by Type (2020-2025)

Table 52. Global Pet Whole Blood and Blood Components Sales (KL) by Type (2026-2031)

Table 53. Global Pet Whole Blood and Blood Components Sales Market Share by Type (2020-2025)

Table 54. Global Pet Whole Blood and Blood Components Sales Market Share by Type (2026-2031)

Table 55. Global Pet Whole Blood and Blood Components Revenue (US$ Million) by Type (2020-2025)

Table 56. Global Pet Whole Blood and Blood Components Revenue (US$ Million) by Type (2026-2031)

Table 57. Global Pet Whole Blood and Blood Components Revenue Market Share by Type (2020-2025)

Table 58. Global Pet Whole Blood and Blood Components Revenue Market Share by Type (2026-2031)

Table 59. Global Pet Whole Blood and Blood Components Price (US$/L) by Type (2020-2025)

Table 60. Global Pet Whole Blood and Blood Components Price (US$/L) by Type (2026-2031)

Table 61. Global Pet Whole Blood and Blood Components Sales (KL) by Application (2020-2025)

Table 62. Global Pet Whole Blood and Blood Components Sales (KL) by Application (2026-2031)

Table 63. Global Pet Whole Blood and Blood Components Sales Market Share by Application (2020-2025)

Table 64. Global Pet Whole Blood and Blood Components Sales Market Share by Application (2026-2031)

Table 65. Global Pet Whole Blood and Blood Components Revenue (US$ Million) by Application (2020-2025)

Table 66. Global Pet Whole Blood and Blood Components Revenue (US$ Million) by Application (2026-2031)

Table 67. Global Pet Whole Blood and Blood Components Revenue Market Share by Application (2020-2025)

Table 68. Global Pet Whole Blood and Blood Components Revenue Market Share by Application (2026-2031)

Table 69. Global Pet Whole Blood and Blood Components Price (US$/L) by Application (2020-2025)

Table 70. Global Pet Whole Blood and Blood Components Price (US$/L) by Application (2026-2031)

Table 71. Thermo Fisher Scientific Company Information

Table 72. Thermo Fisher Scientific Description and Business Overview

Table 73. Thermo Fisher Scientific Pet Whole Blood and Blood Components Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)

Table 74. Thermo Fisher Scientific Pet Whole Blood and Blood Components Product

Table 75. Thermo Fisher Scientific Recent Developments/Updates

Table 76. Moregate BioTech Company Information

Table 77. Moregate BioTech Description and Business Overview

Table 78. Moregate BioTech Pet Whole Blood and Blood Components Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)

Table 79. Moregate BioTech Pet Whole Blood and Blood Components Product

Table 80. Moregate BioTech Recent Developments/Updates

Table 81. Bovogen Biologicals (ANZCO Foods Healthcare) Company Information

Table 82. Bovogen Biologicals (ANZCO Foods Healthcare) Description and Business Overview

Table 83. Bovogen Biologicals (ANZCO Foods Healthcare) Pet Whole Blood and Blood Components Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)

Table 84. Bovogen Biologicals (ANZCO Foods Healthcare) Pet Whole Blood and Blood Components Product

Table 85. Bovogen Biologicals (ANZCO Foods Healthcare) Recent Developments/Updates

Table 86. Pel-Freez, LLC Company Information

Table 87. Pel-Freez, LLC Description and Business Overview

Table 88. Pel-Freez, LLC Pet Whole Blood and Blood Components Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)

Table 89. Pel-Freez, LLC Pet Whole Blood and Blood Components Product

Table 90. Pel-Freez, LLC Recent Developments/Updates

Table 91. HemoStat Laboratories Company Information

Table 92. HemoStat Laboratories Description and Business Overview

Table 93. HemoStat Laboratories Pet Whole Blood and Blood Components Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)

Table 94. HemoStat Laboratories Pet Whole Blood and Blood Components Product

Table 95. HemoStat Laboratories Recent Developments/Updates

Table 96. CellSera Australia (Auckland BioSciences) Company Information

Table 97. CellSera Australia (Auckland BioSciences) Description and Business Overview

Table 98. CellSera Australia (Auckland BioSciences) Pet Whole Blood and Blood Components Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)

Table 99. CellSera Australia (Auckland BioSciences) Pet Whole Blood and Blood Components Product

Table 100. CellSera Australia (Auckland BioSciences) Recent Developments/Updates

Table 101. Animal Technologies Company Information

Table 102. Animal Technologies Description and Business Overview

Table 103. Animal Technologies Pet Whole Blood and Blood Components Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)

Table 104. Animal Technologies Pet Whole Blood and Blood Components Product

Table 105. Animal Technologies Recent Developments/Updates

Table 106. Serana Europe Company Information

Table 107. Serana Europe Description and Business Overview

Table 108. Serana Europe Pet Whole Blood and Blood Components Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)

Table 109. Serana Europe Pet Whole Blood and Blood Components Product

Table 110. Serana Europe Recent Developments/Updates

Table 111. Lake Immunogenics Company Information

Table 112. Lake Immunogenics Description and Business Overview

Table 113. Lake Immunogenics Pet Whole Blood and Blood Components Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)

Table 114. Lake Immunogenics Pet Whole Blood and Blood Components Product

Table 115. Lake Immunogenics Recent Developments/Updates

Table 116. MoreCare. Inc. Company Information

Table 117. MoreCare. Inc. Description and Business Overview

Table 118. MoreCare. Inc. Pet Whole Blood and Blood Components Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)

Table 119. MoreCare. Inc. Pet Whole Blood and Blood Components Product

Table 120. MoreCare. Inc. Recent Developments/Updates

Table 121. Nanjing BioChannel Biotechnology Co., Ltd Company Information

Table 122. Nanjing BioChannel Biotechnology Co., Ltd Description and Business Overview

Table 123. Nanjing BioChannel Biotechnology Co., Ltd Pet Whole Blood and Blood Components Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)

Table 124. Nanjing BioChannel Biotechnology Co., Ltd Pet Whole Blood and Blood Components Product

Table 125. Nanjing BioChannel Biotechnology Co., Ltd Recent Developments/Updates

Table 126. Key Raw Materials Lists

Table 127. Raw Materials Key Suppliers Lists

Table 128. Pet Whole Blood and Blood Components Distributors List

Table 129. Pet Whole Blood and Blood Components Customers List

Table 130. Pet Whole Blood and Blood Components Market Trends

Table 131. Pet Whole Blood and Blood Components Market Drivers

Table 132. Pet Whole Blood and Blood Components Market Challenges

Table 133. Pet Whole Blood and Blood Components Market Restraints

Table 134. Research Programs/Design for This Report

Table 135. Key Data Information from Secondary Sources

Table 136. Key Data Information from Primary Sources

Table 137. Authors List of This Report

List of Figures

Figure 1. Product Picture of Pet Whole Blood and Blood Components

Figure 2. Global Pet Whole Blood and Blood Components Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Pet Whole Blood and Blood Components Market Share by Type: 2024 & 2031

Figure 4. Canine Product Picture

Figure 5. Feline Product Picture

Figure 6. Bovine Product Picture

Figure 7. Sheep Product Picture

Figure 8. Others Product Picture

Figure 9. Global Pet Whole Blood and Blood Components Market Value by Components, (US$ Million) & (2020-2031)

Figure 10. Global Pet Whole Blood and Blood Components Market Share by Components: 2024 VS 2031

Figure 11. Pet Whole Blood Product Picture

Figure 12. Blood Components Product Picture

Figure 13. Global Pet Whole Blood and Blood Components Market Value by Application (2020-2031) & (US$ Million)

Figure 14. Global Pet Whole Blood and Blood Components Market Share by Application: 2024 & 2031

Figure 15. Veterinary Hospital

Figure 16. Clinic

Figure 17. Other

Figure 18. Global Pet Whole Blood and Blood Components Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 19. Global Pet Whole Blood and Blood Components Market Size (2020-2031) & (US$ Million)

Figure 20. Global Pet Whole Blood and Blood Components Sales (2020-2031) & (KL)

Figure 21. Global Pet Whole Blood and Blood Components Average Price (US$/L) & (2020-2031)

Figure 22. Pet Whole Blood and Blood Components Report Years Considered

Figure 23. Pet Whole Blood and Blood Components Sales Share by Manufacturers in 2024

Figure 24. Global Pet Whole Blood and Blood Components Revenue Share by Manufacturers in 2024

Figure 25. Global 5 and 10 Largest Pet Whole Blood and Blood Components Players: Market Share by Revenue in Pet Whole Blood and Blood Components in 2024

Figure 26. Pet Whole Blood and Blood Components Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 27. Global Pet Whole Blood and Blood Components Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 28. North America Pet Whole Blood and Blood Components Sales Market Share by Country (2020-2031)

Figure 29. North America Pet Whole Blood and Blood Components Revenue Market Share by Country (2020-2031)

Figure 30. United States Pet Whole Blood and Blood Components Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Canada Pet Whole Blood and Blood Components Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Europe Pet Whole Blood and Blood Components Sales Market Share by Country (2020-2031)

Figure 33. Europe Pet Whole Blood and Blood Components Revenue Market Share by Country (2020-2031)

Figure 34. Germany Pet Whole Blood and Blood Components Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. France Pet Whole Blood and Blood Components Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. U.K. Pet Whole Blood and Blood Components Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. Italy Pet Whole Blood and Blood Components Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. Russia Pet Whole Blood and Blood Components Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Asia Pacific Pet Whole Blood and Blood Components Sales Market Share by Region (2020-2031)

Figure 40. Asia Pacific Pet Whole Blood and Blood Components Revenue Market Share by Region (2020-2031)

Figure 41. China Pet Whole Blood and Blood Components Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Japan Pet Whole Blood and Blood Components Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. South Korea Pet Whole Blood and Blood Components Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. India Pet Whole Blood and Blood Components Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Australia Pet Whole Blood and Blood Components Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. China Taiwan Pet Whole Blood and Blood Components Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Southeast Asia Pet Whole Blood and Blood Components Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Latin America Pet Whole Blood and Blood Components Sales Market Share by Country (2020-2031)

Figure 49. Latin America Pet Whole Blood and Blood Components Revenue Market Share by Country (2020-2031)

Figure 50. Mexico Pet Whole Blood and Blood Components Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Brazil Pet Whole Blood and Blood Components Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. Argentina Pet Whole Blood and Blood Components Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Colombia Pet Whole Blood and Blood Components Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. Middle East and Africa Pet Whole Blood and Blood Components Sales Market Share by Country (2020-2031)

Figure 55. Middle East and Africa Pet Whole Blood and Blood Components Revenue Market Share by Country (2020-2031)

Figure 56. Turkey Pet Whole Blood and Blood Components Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 57. Saudi Arabia Pet Whole Blood and Blood Components Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 58. UAE Pet Whole Blood and Blood Components Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 59. Global Sales Market Share of Pet Whole Blood and Blood Components by Type (2020-2031)

Figure 60. Global Revenue Market Share of Pet Whole Blood and Blood Components by Type (2020-2031)

Figure 61. Global Pet Whole Blood and Blood Components Price (US$/L) by Type (2020-2031)

Figure 62. Global Sales Market Share of Pet Whole Blood and Blood Components by Application (2020-2031)

Figure 63. Global Revenue Market Share of Pet Whole Blood and Blood Components by Application (2020-2031)

Figure 64. Global Pet Whole Blood and Blood Components Price (US$/L) by Application (2020-2031)

Figure 65. Pet Whole Blood and Blood Components Value Chain

Figure 66. Channels of Distribution (Direct Vs Distribution)

Figure 67. Bottom-up and Top-down Approaches for This Report

Figure 68. Data Triangulation

Figure 69. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions